PCF-sponsored consensus proposes cardiovascular risk triage schema for men on ADT/ARPi therapy
Review · JCO Oncol Pract · 2026-09-29. Number 3 in the UrologyWatch Top 5 for September 29, 2026.
A narrative review and clinician-industry consensus proposes a three-tier (high/intermediate/low) point-of-care schema to identify prostate cancer patients on hormone therapy who need cardiovascular referral, based on prior CVD events and risk-factor control.
Why it matters: Offers a practical framework for urologists to flag cardiovascular risk in ADT/ARPi patients before formal validation studies are completed.
Source: JCO Oncol Pract · PubMed 42804714 · DOI 10.1200/op-26-00312
Loading today's edition…